[Experiences on the treatment of cerebral insufficiency and peripheral circulation disorders with the test preparation EP 50-100].
D000368:Aged; D002561:Cerebrovascular Disorders / Q000188:drug therapy*; D003704:Dementia / Q000188:drug therapy; D005260:Female; D006801:Humans; D007383:Intermittent Claudication / Q000188:drug therapy; D008297:Male; D000432:Methanol / Q000627:therapeutic use; D008875:Middle Aged; D009422:Nervous System Diseases / Q000188:drug therapy; D019965:Neurocognitive Disorders / Q000188:drug therapy; D010847:Picolines / Q000627:therapeutic use*; D011725:Pyridines / Q000627:therapeutic use*; D011928:Raynaud Disease / Q000188:drug therapy; D013440:Sulfides / Q000627:therapeutic use; D014652:Vascular Diseases / Q000188:drug therapy*; D014665:Vasodilator Agents / Q000627:therapeutic use*
D010847:Picolines; D011725:Pyridines; D013440:Sulfides; D014665:Vasodilator Agents; D000432:Methanol
Erfahrungen über eine Behandlung von zerebraler Insuffizienz und peripheren Durchblutungsstörungen mit dem Versuchspräparat EP 50-100.